Hercules Capital, Inc.

HTGC · New York Stock Exchange · USD

16,37USD

+0,21 (+1,30 %)Stand 9. Nov., 21:00

Nachbörslich16,370,00 (0,00 %)19:51 ET

Vortag 16,16

Kennzahlen

Eröffnung
16,25
Vortag
16,16
Tagesspanne
16,13 – 16,42
52 Wochen
13,70 – 19,13
Volumen
2,03 Mio.
Ø Volumen
1,44 Mio.
Börsenwert
3,1 Mrd. $
KGV
8,5
Gewinn je Aktie (TTM)
1,82
Dividendenrendite
11,9 %
Beta
0,8
Nächste Zahlen
11. Feb. 2027

Finanzen

USDFY 2025FY 2024FY 2023FY 2022FY 2021
Umsatz547,1 Mio.430,9 Mio.494,12 Mio.239,39 Mio.309,58 Mio.
Herstellungskosten69,84 Mio.77,15 Mio.67,62 Mio.54,75 Mio.54,45 Mio.
Bruttogewinn477,25 Mio.353,75 Mio.426,5 Mio.184,64 Mio.255,14 Mio.
Forschung und Entwicklung00000
Vertrieb und Verwaltung19,03 Mio.19,67 Mio.18,7 Mio.16,95 Mio.16,11 Mio.
Operatives Ergebnis365,16 Mio.262,97 Mio.337,48 Mio.102,08 Mio.174,16 Mio.
EBITDA365,43 Mio.263,43 Mio.337,67 Mio.102,29 Mio.174,47 Mio.
Nettogewinn339,74 Mio.262,97 Mio.337,48 Mio.102,08 Mio.174,16 Mio.
Gewinn je Aktie (verwässert)1,851,612,310,791,49

Bewertung

Letzte 12 Monate

KGV
8,5
Kurs-Umsatz-Verhältnis
5,7
Kurs-Buchwert-Verhältnis
1,3
PEG
0,9
Bruttomarge
93,1 %
Operative Marge
80,3 %
Nettomarge
65,1 %
Verschuldungsgrad
1,1
EV/EBITDA
12,8
Eigenkapitalrendite
15,8 %
Kapitalrendite (ROIC)
9,0 %
Free-Cashflow-Rendite
−5,0 %
FY 2025FY 2024FY 2023FY 2022FY 2021
Bruttomarge87,2 %82,1 %86,3 %77,1 %82,4 %
Operative Marge66,7 %61,0 %68,3 %42,6 %56,3 %
Nettomarge62,1 %61,0 %68,3 %42,6 %56,3 %
KGV9,912,57,216,511,1
Kurs-Umsatz-Verhältnis6,27,54,96,96,1
Kurs-Buchwert-Verhältnis1,51,61,31,21,5
Verschuldungsgrad1,00,90,91,11,0
Liquidität 3. Grades1,41,41,01,20,4
Dividendenrendite9,6 %9,4 %11,4 %14,8 %9,2 %
Unternehmenswert5,65 Mrd.4,91 Mrd.3,86 Mrd.3,22 Mrd.3,01 Mrd.
EV/EBITDA15,518,611,431,517,3
Eigenkapitalrendite15,3 %13,2 %18,7 %7,3 %13,3 %
Kapitalrendite (ROIC)835,3 %653,1 %10,0 %3,4 %6,8 %
Free-Cashflow-Rendite−12,5 %−3,7 %2,8 %−25,7 %6,8 %

Wachstum

FY 2025FY 2024FY 2023FY 2022FY 2021
Umsatz+27,0 %−12,8 %+106,4 %−22,7 %−13,4 %
Bruttogewinn+34,9 %−17,1 %+131,0 %−27,6 %−14,3 %
Operatives Ergebnis+38,9 %−22,1 %+230,6 %−41,4 %−23,4 %
Nettogewinn+29,2 %−22,1 %+230,6 %−41,4 %−23,4 %
Gewinn je Aktie+14,9 %−30,3 %+192,4 %−47,0 %−25,9 %
Freier Cashflow−258,5 %−276,3 %+115,9 %−430,6 %−38,1 %
Dividende je Aktie−4,3 %−0,8 %−3,0 %+28,0 %+12,4 %

Analysten

Einstufungen · Buy

  • 0Stark kaufen
  • 19Kaufen
  • 11Halten
  • 1Verkaufen
  • 0Stark verkaufen

Kursziel

15,50

Durchschnitt · −5,31 %

Tief 15,50Aktuell 16,37Hoch 15,50

Schätzungen

FY 2026FY 2027FY 2028
Umsatz (Ø)582,63 Mio.632,49 Mio.680,65 Mio.
Umsatz (Tief – Hoch)572,63 Mio. – 598,95 Mio.621,64 Mio. – 650,21 Mio.650,92 Mio. – 739,58 Mio.
Gewinn je Aktie (Ø)1,921,951,99
Gewinn je Aktie (Tief – Hoch)1,91 – 1,991,91 – 1,991,89 – 2,08
Analysten566

Letzte Änderungen

  • UBS1. Sept. 2026Neutral → Buy
  • Ladenburg Thalmann31. Juli 2026Buy
  • UBS18. Mai 2026Neutral
  • Piper Sandler6. Mai 2026Neutral
  • Citizens22. Apr. 2026Market Outperform
  • Keefe, Bruyette & Woods16. Apr. 2026Outperform
  • Piper Sandler7. Apr. 2026Neutral
  • UBS13. März 2026Neutral

Quartalszahlen

Nächste Zahlen: 11. Feb. 2027
Okt. 2026Juli 2026Mai 2026Feb. 2026Okt. 2025Juli 2025Mai 2025Feb. 2025
Gewinn je Aktie · Erwartet0,470,480,470,480,480,470,460,51
Gewinn je Aktie · Tatsächlich0,470,500,480,480,490,500,450,49
Abweichung−1,03 %+3,14 %+2,13 %0,00 %+2,08 %+6,38 %−2,17 %−3,92 %
Umsatz · Tatsächlich140,12 Mio.149,1 Mio.141,54 Mio.137,4 Mio.169,31 Mio.79,84 Mio.102,1 Mio.47,93 Mio.

Dividenden und Splits

Ex-TagZahltagBetrag
10. Nov. 202617. Nov. 20260,47
11. Aug. 202618. Aug. 20260,47
14. Mai 202621. Mai 20260,47
25. Feb. 20264. März 20260,47
12. Nov. 202519. Nov. 20250,54
12. Aug. 202519. Aug. 20250,47
13. Mai 202520. Mai 20250,54
26. Feb. 20255. März 20250,54
13. Nov. 202420. Nov. 20240,48
13. Aug. 202420. Aug. 20240,48
13. Mai 202421. Mai 20240,56
27. Feb. 20246. März 20240,48

Aktiensplits

–

Eigentümer

Institutionen

Q2 2026 · 13F

Anteil institutioneller Investoren
28,24 %
Investoren mit 13F-Meldung
345

Größte Investoren

  • VAN ECK ASSOCIATES CORP2,09 %3,88 Mio.
  • SOUND INCOME STRATEGIES, LLC1,98 %3,67 Mio.
  • CITADEL ADVISORS LLC1,58 %2,94 Mio.
  • UBS GROUP AG1,43 %2,65 Mio.
  • TWO SIGMA INVESTMENTS, LP1,22 %2,27 Mio.
  • LPL FINANCIAL LLC1,00 %1,86 Mio.
  • MORGAN STANLEY0,98 %1,81 Mio.
  • LEGAL & GENERAL GROUP PLC0,91 %1,68 Mio.

Insider-Geschäfte

  • Meyer Seth H9. Okt. 2026 · officer: PresidentVerkauf3011 Aktien · 16,51
  • Meyer Seth H9. Okt. 2026 · officer: PresidentVerkauf3458 Aktien · 16,51
  • Bluestein Scott9. Okt. 2026 · director, officer: Chief Executive OfficerVerkauf9741 Aktien · 16,51
  • Bluestein Scott9. Okt. 2026 · director, officer: Chief Executive OfficerVerkauf10.652 Aktien · 16,51
  • Botelho Kiersten Zaza9. Okt. 2026 · officer: Chief Legal Officer & CCOVerkauf1018 Aktien · 16,51
  • Botelho Kiersten Zaza9. Okt. 2026 · officer: Chief Legal Officer & CCOVerkauf956 Aktien · 16,51
  • Follmann Christian9. Okt. 2026 · officer: Chief Operating OfficerVerkauf1365 Aktien · 16,51
  • Follmann Christian9. Okt. 2026 · officer: Chief Operating OfficerVerkauf1433 Aktien · 16,51

Vergleichbare Unternehmen

Über das Unternehmen

Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels, and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, drug platform, development, and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. Within sustainable and renewables, it invests in Vehicle Technology, Energy Generation and Storage, Ag Technology, Advanced Materials, and Industry 4.0. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest, particularly in the areas of software, biotech, and information services. The firm prefers to invest between $5 million and $500 million in equity per transactions. It invests in debt between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in San Mateo, California with additional offices in North America and Europe.

Führung

  • Scott BluesteinCEO, Chief Investment Officer & Director
  • Seth Hardy MeyerPresident
  • Christian FollmannChief Operating Officer
  • Kiersten Zaza BotelhoChief Legal Officer, Chief Compliance Officer & Corporate Secretary
  • Andrew Jordan OlsonChief Financial Officer
  • Michael W. HaraManaging Director of Investor Relations & Corporation Communications
CEO
Scott Bluestein
Mitarbeitende
100
Hauptsitz
San Mateo, CA, US
Sektor
Financial Services
Branche
Asset Management
Börsengang
9. Juni 2005
Website
htgc.com

Nachrichten

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.